Citation Impact
Citing Papers
Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group.
1992
Vascular Endothelial Growth Factor Expression in Ovarian Cancer: A Model for Targeted Use of Novel Therapies?
2008
Risk Factors for Venous Thromboembolism
2003 Standout
( R )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
2013 StandoutScienceNobel
Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes
2002
Ross operation in children and young adults: the Alder Hey case series
2004
Normal and abnormal transformation of the spiral arteries during pregnancy
2006
MORPHOLOGICAL CHANGES OF THE SPIRAL ARTERIES IN THE PLACENTAE BED IN RELATION TO PRE‐ECLAMPSIA AND FETAL GROWTH RETARDATION
1981
Uterine Artery Doppler Flow and Uteroplacental Vascular Pathology in Normal Pregnancies and Pregnancies Complicated by Pre-eclampsia and Small for Gestational Age Fetuses
2001
A checkpoint regulates the rate of progression through S phase in S. cerevisiae in Response to DNA damage
1995 StandoutNobel
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data
2007 Standout
Gene Sets Identified with Oncogene Cooperativity Analysis Regulate In Vivo Growth and Survival of Leukemia Stem Cells
2012
The Human Placental Bed Revisited
2002
The relation of increased uterine artery blood flow resistance and impaired trophoblast invasion in pre-eclamptic pregnancies
2005
Prognosis of Cancers Associated with Venous Thromboembolism
2000 Standout
Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia
1994
Fourteen-year experience with homovital homografts for aortic valve replacement
1995
A Reversible Posterior Leukoencephalopathy Syndrome
1996 Standout
G Protein-coupled Receptor Kinase 5 in Cultured Vascular Smooth Muscle Cells and Rat Aorta
1997 StandoutNobel
Histological features of uteroplacental vessels in normal and hypertensive patients in relation to birthweight
1989
Elevated ambulatory blood pressure in 20 subjects with Williams syndrome
1999
Hemodynamic and clinical impact of prosthesis–patient mismatch in the aortic valve position and its prevention
2000
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation
2008
The myometrial junctional zone spiral arteries in normal and abnormal pregnancies
2002
Deep-Vein Thrombosis and the Incidence of Subsequent Symptomatic Cancer
1992
Uric Acid and Cardiovascular Risk
2008 Standout
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre‐eclampsia and its complications
1998
Trans Fatty Acids and Cardiovascular Disease
2006 Standout
Sleep effects on ambulatory blood pressure measurements in pregnant women
2001
Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men
1995 Standout
Late sporadic miscarriage is associated with abnormalities in spiral artery transformation and trophoblast invasion
2006
Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: Soluble Tie-2
2008
Comparative Pharmacology of Newer Progestogens
1996
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
2011 Standout
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
2005 Standout
Simultaneous determination of ethamsylate, tramadol and lidocaine in human urine by capillary electrophoresis with electrochemiluminescence detection
2006
Renin-like immunoreactivity in uterus and placenta from normotensive and hypertensive pregnancies
1998
Chronotherapy With Low-Dose Aspirin for Prevention of Complications in Pregnancy
2012
Antiplatelet agents for preventing pre-eclampsia and its complications
2003
Pre-eclampsia
2000
Pre-eclampsia: more than pregnancy-induced hypertension
1993
Placental bed biopsies in placental abruption
1992
The Comparison of Uterine Artery Doppler Velocimetry with the Histopathology of the Placental Bed
1999
Williams–Beuren Syndrome
2010 Standout
Oral Contraceptives and the Risk of Venous Thrombosis
2001
Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension
2004
Maternal and child undernutrition: global and regional exposures and health consequences
2008 Standout
Color Doppler ultrasound of spiral artery blood flow for prediction of hypertensive disorders and intra uterine growth restriction: a longitudinal study
2007
Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy
2010 Standout
Immune Thrombocytopenic Purpura
2002 Standout
Heparin-Induced Thrombocytopenia
2006 Standout
The Antiphospholipid Syndrome
2002 Standout
A Prospective Study of Venous Thromboembolism after Major Trauma
1994 Standout
Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age
2008
A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre‐eclamptic pregnancies
1994
The Ross operation: a 12-year experience
1999
Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus
2004
Intrauterine Infection and Preterm Delivery
2000 Standout
Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
2008 Standout
Long-term performance of heart valve prostheses
2000
Renal Vascular and Thrombotic Effects of Cyclosporine
1989
Burden of valvular heart diseases: a population-based study
2006 Standout
Review: Microbial colonization of prosthetic devices
1987
Polycystic Ovary Syndrome
2005 Standout
Preeclampsia: An endothelial cell disorder
1989 Standout
The “Great Obstetrical Syndromes” are associated with disorders of deep placentation
2010 Standout
Cancer and venous thromboembolism
1996
Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.
1996
A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia
2009
A Randomized Controlled Trial of Aspirin in Patients With Abnormal Uterine Artery Blood Flow
1996
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 Standout
The detection, investigation and management of hypertension in pregnancy: full consensus statement
2000
Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes
2003
Disseminated Intravascular Coagulation
1999 Standout
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
2006 Standout
Homograft replacement of the mitral valve
1996
Double blind, cluster randomised trial of low dose supplementation with vitamin A or beta carotene on mortality related to pregnancy in Nepal
1999
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
2017 Standout
Implantation and the placenta: key pieces of the development puzzle
1994 StandoutScience
Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle
2013 StandoutNobel
Prevention of Venous Thromboembolism
1998
On an Anatomical Basis for the Increase in Birth Weight in Second and Subsequent Born Children
2003
Blood Coagulation and Oral Contraceptives
1998
Plasma placenta growth factor levels in midtrimester pregnancies
2001
Thrombosis of the Cerebral Veins and Sinuses
2005 Standout
Circulating Angiogenic Factors and the Risk of Preeclampsia
2004 Standout
Preeclampsia: An excessive maternal inflammatory response to pregnancy
1999 Standout
Antiplatelet agents for preventing pre-eclampsia and its complications
2007
The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits
1982
Low-affinity heparin potentiates the action of high-affinity heparin oligosaccharides
1984
Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy
2005
An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis
1989 StandoutScienceNobel
Plasminogen Activators, Tissue Degradation, and Cancer
1985 Standout
Inadequate maternal vascular response to placentation in pregnancies complicated by pre‐eclampsia and by small‐for‐gestational age infants
1986 Standout
Pregnancy-associated thrombocytopenia: pathogenesis and management
1992
Diagnostic procedures and long-term prognosis in bilateral renal cortical necrosis
1973
Prevention of Venous Thromboembolism
1992
The Placental Bed
1996
Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene
2004 StandoutNobel
First Trimester Placental Growth Factor and Soluble Fms-Like Tyrosine Kinase 1 and Risk for Preeclampsia
2004
The Effect of Progesterone on the Haemostatic Mechanism
1997
Risks of Anticoagulant Therapy in Pregnant Women with Artificial Heart Valves
1986
The human placental bed: Electron microscopic study of trophoblastic invasion of spiral arteries
1980
Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy
1983
Risk Factors for Peripartum and Postpartum Stroke and Intracranial Venous Thrombosis
2000
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Elevated Amniotic Fluid Interleukin‐6 Levels During the Early Second Trimester Are Associated With Greater Risk of Subsequent Preterm Delivery
1997
Biomaterial-Centered Infection: Microbial Adhesion Versus Tissue Integration
1987 StandoutScience
Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
1990 StandoutNobel
Glomerular endotheliosis in normal pregnancy and pre‐eclampsia
2003
Multiple receptors for dopamine
1979 StandoutNature
Prevention of perinatal death and adverse perinatal outcome using low‐dose aspirin: a meta‐analysis
2013
Therapeutic implications of disseminated intravascular coagulation
1967
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant
1982
Use of Antithrombotic Agents During Pregnancy
1995
Ultra-Early Hemostatic Therapy for Intracerebral Hemorrhage
2003
Electrogenerated Chemiluminescence and Its Biorelated Applications
2008 Standout
Low-Molecular-Weight Heparins
1997 Standout
Preterm labor: One syndrome, many causes
2014 StandoutScience
Growth and sporulation characteristics of Bacillus megaterium under different conditions of nutrient limitation
1974
Prevention of Venous Thromboembolism
1995
Prolactin
1977
Tumors: Wounds That Do Not Heal
1986 Standout
The incidence and gene frequency of ataxia-telangiectasia in the United States.
2020
Prevalence and Prognosis in Anorexia Nervosa
1977
Effect of Oral Contraceptives on Haemostasis Variables
1997
BECLOMETHASONE AEROSOL IN CHRONIC BRONCHIAL ASTHMA
1974
Running — An Analogue of Anorexia?
1983 Standout
Uric Acid Is as Important as Proteinuria in Identifying Fetal Risk in Women With Gestational Hypertension
2005
Dietary Protein Intake and the Progressive Nature of Kidney Disease:
1982 Standout
FETAL GROWTH RETARDATION AND THE ARTERIES OF THE PLACENTAL BED
1977
Works of J. Bonnar being referenced
Fibrinolytic Enzyme System and Pregnancy
1969
Fibrin Degradation Products in Normal and Abnormal Pregnancy and Parturition
1969
Early platelet consumption in pre-eclampsia.
1978
Pituitary sensitivity to 50 micro g LH/FSH-RH in subjects with anorexia nervosa in acute and recovery stages.
1975
Comparative studies of 30 μg ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and platelets
1990
Uteroplacental Hemostasis in Intrauterine Fetal Growth Retardation
1999
Potential predictors of chemotherapy response in ovarian cancer—How do we define chemosensitivity?
2006
Low Molecular Weight Heparin for Thromboprophylaxis during Caesarean Section
1999
The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives
1996
Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid
1996
The plasminogen activator urokinase and its inhibitor PAI-2 in endometrial cancer
1992
Haemostatic risk factors in healthy postmenopausal women taking hormone replacement therapy
2002
Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies
1998
Coagulation effects of oral contraception
1987
Oral contraceptives and blood coagulation.
1986
The Measurement of Heparin
1973
Clinical applications of fibrinolytic inhibition in gynaecology
1980
Renal function in preeclampsia
1976
Effect of breast-feeding on pituitary-ovarian function after childbirth
1975
Reversed Diurnal Blood Pressure Rhythm in Hypertensive Pregnancies
1976
SCANNING AND TRANSMISSION ELECTRON MICROSCOPY OF MATERIAL ADHERENT TO INTRAUTERINE CONTRACEPTIVE DEVICES
1980
PREVENTION OF THROMBOSIS AFTER PELVIC SURGERY BY BRITISH DEXTRAN 70
1972
The placental bed biopsy: Review from three European centers
1986
Estrogen dose and progestogen type: Their effect on hemostatic changes in oral contraceptive users
1996
An ultrastructural study of menstrual blood in normal menstruation and dysfunctional uterine bleeding
1983
Effect of Oestrogen Dose on Whole Blood Platelet Activation in Women Taking New Low Dose Oral Contraceptives
1994
SUBCUTANEOUS HEPARIN
1974
TREATMENT OF HYPERTENSION IN PREGNANCY WITH METHYLDOPA: BLOOD PRESSURE CONTROL AND SIDE EFFECTS
1977
THE ULTRASTRUCTURE OF THE ARTERIAL SUPPLY OF THE HUMAN PLACENTA IN EARLY AND LATE PREGNANCY
1974
AN ULTRASTRUCTURAL STUDY OF UTERO‐PLACENTAL SPIRAL ARTERIES IN HYPERTENSIVE AND NORMOTENSIVE PREGNANCY AND FETAL GROWTH RETARDATION
1981
Treatment of fetal growth retardation in utero with heparin and dipyridamole
1975
Increased whole blood platelet aggregation in oral contraceptive users can be preventedin vitroby a thromboxane synthetase inhibitor
1996
SCANNING ELECTRON MICROSCOPY OF THE HUMAN PLACENTA AND DECIDUAL SPIRAL ARTERIES IN NORMAL PREGNANCY
1974
A STUDY OF PULMONARY EMBOLISM AND DEEP LEG VEIN THROMBOSIS AFTER MAJOR GYNAECOLOGICAL SURGERY USING LABELLED FIBRINOGEN‐PHLEBOGRAPHY AND LUNG SCANNING
1974
EFFECT OF SYNTHETIC GONADOTROPHIN-RELEASING HORMONE IN SECONDARY AMENORRHŒA
1972
PLASMA-URATE MEASUREMENTS IN PREDICTING FETAL DEATH IN HYPERTENSIVE PREGNANCY
1976
PRENATAL DIAGNOSIS OF SPINA BIFIDA AND ANENCEPHALY BY MATERNAL SERUM-ALPHA-FETOPROTEIN MEASUREMENT
1974
HÆMORRHAGIC DIATHESIS DUE TO ABRUPTIO PLACENTÆ TREATED BY FIBRINOGEN, ∈-AMINOCAPROIC ACID, AND HYSTEROTOMY
1965
THE ULTRASTRUCTURE OF THE ARTERIAL SUPPLY OF THE HUMAN PLACENTA IN PREGNANCY COMPLICATED BY FETAL GROWTH RETARDATION
1976
EARLY PLATELET CONSUMPTION IN PRE-ECLAMPSIA
1978
Venous Thromboembolism and Pregnancy
1981
The fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acid
1987
Comparison of blood levels of vitamin A, beta-carotene and vitamin E in abruptio placentae with normal pregnancy.
1986
Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel.
1983
PLASMINOGEN ACTIVATORS IN THE ENDOMETRIUM OF WOMEN USING INTRAUTERINE CONTRACEPTIVE DEVICES
1976